or Try an Advanced Search...

    Bipolar Depression Stocks List

    Symbol Grade Name % Change
    LLY D Eli Lilly and Company 0.75
    NRXP F NeuroRx, Inc. -1.24
    View As Page of Charts
    Related Industries: Conglomerates Drug Manufacturers - Major
    Related Stock Lists: Bipolar Disorder Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Antidepressants Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Bacterial Infections Benign Prostatic Hyperplasia Cardiovascular Products Cattle Central Nervous System Disorders Cholesterol Depression Depressive Disorder Diabetes Dog Dysfunction

    Related ETFs - A few ETFs which own one or more of the above listed Bipolar Depression stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 21.61
    OZEM D Roundhill GLP-1 & Weight Loss ETF 19.98
    MEDX D Horizon Kinetics Medical ETF 16.63
    THNR D Amplify Weight Loss Drug & Treatment ETF 14.78
    PPH D Market Vectors Pharmaceutical ETF 12.88
    View all Bipolar Depression ETFs...
    Compare ETFs
    Compare IHE to PPH Compare MEDX to PPH Compare MEDX to THNR

        Bipolar Depression Stocks Recent News

        Date Stock Title
        Oct 2 LLY Jim Cramer Remains Steadfast On Eli Lilly and Company (NYSE:LLY)
        Oct 2 LLY Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
        Oct 2 LLY Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
        Oct 2 LLY Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
        Oct 2 LLY Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
        Oct 2 LLY Eli Lilly Building $4.5B Pharmaceutical Factory in Indiana
        Oct 2 LLY Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
        Oct 2 LLY Eli Lilly Plans $4.5 Billion Research Hub
        Oct 2 LLY Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
        Oct 2 LLY Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
        Oct 2 LLY Eli Lilly is building a $4.5 billion factory to speed up drug production
        Oct 2 LLY Eli Lilly announces $4.5B production/R&D site in Indiana
        Oct 2 LLY Lilly to invest $4.5B on new Indiana facility
        Oct 2 LLY Lilly to invest $4.5 billion on new Indiana facility
        Oct 2 LLY Lilly announces new $4.5 billion site - the Lilly Medicine Foundry - to drive innovation in drug production and make medicines for clinical trials
        Oct 2 LLY Lilly plans $4.5B ‘foundry’ for advanced drug manufacturing
        Oct 2 LLY Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
        Oct 1 LLY U.S. port strike expected to have limited impact on healthcare supply chain: HHS
        Oct 1 LLY Here's how AI is set to disrupt healthcare — albeit slowly
        Oct 1 LLY t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
        Related Industries: Conglomerates Drug Manufacturers - Major
        Related Stock Lists: Bipolar Disorder Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Antidepressants Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Bacterial Infections Benign Prostatic Hyperplasia Cardiovascular Products Cattle Central Nervous System Disorders Cholesterol Depression Depressive Disorder Diabetes Dog Dysfunction
        Bipolar Depression

        Bipolar depression is a type of depression that is characterized by extreme mood swings between periods of mania and depression. During a manic episode, a person may feel euphoric, have increased energy, and be more talkative than usual. During a depressive episode, a person may feel hopeless, have difficulty concentrating, and have a decreased interest in activities.

        Browse All Tags